Acquisition

Renewbrook Energy acquires PosiGen's distressed solar assets, promising stability for thousands of customers left in limbo after PosiGen's bankruptcy.

Micromobility giant Dott reports its first-ever annual profit, fueling a massive 45,000-vehicle expansion and signaling a new era of sustainable growth.

Epika Fleet Services expands its national network, partnering with Miami's Freeway Fleet to bolster its presence in the critical Southeast market.

EchoStor secures its spot on CRN's Elite 150 list again, fueled by strategic acquisitions, top industry awards, and a focus on complex enterprise IT.

Mopec Group appoints Scott Nudelman to lead its new Certified Service division, a strategic move to boost lab uptime and gain a competitive edge.

A lucrative deal for a rare disease voucher positions Fortress Biotech for profitability, highlighting a successful strategy and a breakthrough for Menkes patients.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

A five-year pivot from office buildings to luxury apartments culminates in a blockbuster private buyout, validating a risky strategy and igniting the market.

ITF Therapeutics will unveil 10 new data presentations on its Duchenne therapy, DUVYZAT, offering critical new insights on long-term safety and efficacy.

With key investor conferences looming, Phathom Pharmaceuticals is set to showcase strong VOQUEZNA sales and a clear path to 2026 profitability.

Pure Storage rebrands as Everpure and acquires 1touch, betting its future on providing the intelligent data management layer essential for enterprise AI.

Following a series of acquisitions, Southwest Strategies Group rebrands as Bodewell, positioning itself to manage public consent for a new era of US infrastructure.

With a new CEO known for commercial turnarounds, oneworld signals a strategic push for tech integration, customer value, and competitive growth.

A2Z Cust2Mate reports a pivotal quarter with up to $5.2M in Q4 revenue, as the delivery of over 2,000 AI-powered smart carts begins to pay off.

The global packaging giant's new Rosarito plant leverages nearshoring to offer U.S. winemakers faster, more flexible access to premium screwcap closures.

The biotech firm slashed a major acquisition hurdle in a deal with HealthCare Royalty, signaling strong confidence in its cancer drug ZYNLONTA's future.

AI legal service provider DocLegal.ai issues a cease-and-desist to a confusingly similar domain, highlighting growing brand protection risks in tech.

With stockholder approval, Abbott's acquisition of Exact Sciences is set to reshape the cancer diagnostics landscape and accelerate early detection.

A landmark partnership aims to slash BCI development costs from $100M to $5M, accelerating therapies and the quest for a human brain AI model.